Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2013

Open Access 01-12-2013 | Research

Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial

Authors: Elizabeth Lutge, Simon Lewin, Jimmy Volmink, Irwin Friedman, Carl Lombard

Published in: Trials | Issue 1/2013

Login to get access

Abstract

Background

Poverty undermines adherence to tuberculosis treatment. Economic support may both encourage and enable patients to complete treatment. In South Africa, which carries a high burden of tuberculosis, such support may improve the currently poor outcomes of patients on tuberculosis treatment. The aim of this study was to test the feasibility and effectiveness of delivering economic support to patients with pulmonary tuberculosis in a high-burden province of South Africa.

Methods

This was a pragmatic, unblinded, two-arm cluster-randomized controlled trial, where 20 public sector clinics acted as clusters. Patients with pulmonary tuberculosis in intervention clinics (n = 2,107) were offered a monthly voucher of ZAR120.00 (approximately US$15) until the completion of their treatment. Vouchers were redeemed at local shops for foodstuffs. Patients in control clinics (n = 1,984) received usual tuberculosis care.

Results

Intention to treat analysis showed a small but non-significant improvement in treatment success rates in intervention clinics (intervention 76.2%; control 70.7%; risk difference 5.6% (95% confidence interval: -1.2%, 12.3%), P = 0.107). Low fidelity to the intervention meant that 36.2% of eligible patients did not receive a voucher at all, 32.3% received a voucher for between one and three months and 31.5% received a voucher for four to eight months of treatment. There was a strong dose–response relationship between frequency of receipt of the voucher and treatment success (P <0.001).

Conclusions

Our pragmatic trial has shown that, in the real world setting of public sector clinics in South Africa, economic support to patients with tuberculosis does not significantly improve outcomes on treatment. However, the low fidelity to the delivery of our voucher meant that a third of eligible patients did not receive it. Among patients in intervention clinics who received the voucher at least once, treatment success rates were significantly improved. Further operational research is needed to explore how best to ensure the consistent and appropriate delivery of such support to those eligible to receive it.

Trial registration

Current Controlled TrialsISRCTN50689131
Appendix
Available only for authorised users
Literature
1.
Farmer P: The consumption of the poor. Infections and Inequalities: The modern Plagues. 2001, Berkeley and Los Angeles, CA: University of California Press
2.
Dubos R, Dubos J: The White Plague: Tuberculosis, Man and Society. 1996, New Brunswick, NJ: Rutgers University Press, xv
3.
Ploubidis GB, Palmer MJ, Blackmore C, Lim TA, Manissero D, Sandgren A, Semenza JC: Social determinants of tuberculosis in Europe: a prospective ecological study. Eur Respir J. 2012, 40: 925-930. 10.1183/09031936.00184011.CrossRefPubMed
4.
Bates I, Fenton C, Gruber J, Lalloo D, Lara AM, Squire SB, Theobald S, Thomson R, Tolhurst R: Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004, 4 (5): 267-277. 10.1016/S1473-3099(04)01002-3.CrossRefPubMed
5.
Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D: The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009, 374 (9692): 817-834. 10.1016/S0140-6736(09)60951-X.CrossRefPubMed
6.
Andersson N: Tuberculosis and social stratification in South Africa. Int J Health Serv. 1990, 20 (1): 141-165. 10.2190/46PA-UDCA-4VXW-M94U.CrossRefPubMed
7.
Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD: HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009, 374 (9693): 921-933. 10.1016/S0140-6736(09)60916-8.CrossRefPubMedPubMedCentral
8.
Anema A, Vogenthaler N, Frongillo EA, Kadiyala S, Weiser SD: Food insecurity and HIV/AIDS: current knowledge, gaps and research priorities. Current HIV/AIDS Reports. 2009, 6 (4): 224-231. 10.1007/s11904-009-0030-z.CrossRefPubMed
9.
Weiser SD, Frongillo EA, Ragland K, Hogg RS, Riley ED, Bangsberg DR: Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med. 2009, 24 (1): 14-20. 10.1007/s11606-008-0824-5.CrossRefPubMed
10.
Day C, Barron P, Massyn N, Padarath A, English R: District Health Barometer 2010/11. 2012, Durban: Health Systems Trust
11.
Wood R, Lawn SD, Johnstone-Robertson S, Bekker L-G: Tuberculosis control has failed in South Africa – time to reappraise strategy. S Afr Med J. 2010, 100: 111-114.
12.
Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JDH: The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011, 101 (4): 654-662. 10.2105/AJPH.2010.199505.CrossRefPubMedPubMedCentral
13.
Ukwaja KN, Modebe O, Igwenyi C, Alobu I: The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int J Tuberc Lung Dis. 2012, 16 (6): 733-739.PubMed
14.
Munro S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J: Adherence to tuberculosis treatment: a qualitative systematic review of qualitative research. PLOS Medicine. 2007, 4 (7): e238-10.1371/journal.pmed.0040238.CrossRefPubMedPubMedCentral
15.
Zhang T, Tang S, Jun G, Whitehead M: Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health. 2007, 7: 19-10.1186/1471-2458-7-19.CrossRefPubMedPubMedCentral
16.
Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM: Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?. Int J Tuberc Lung Dis. 2005, 9 (3): 263-269.PubMed
17.
Yach D: Tuberculosis in the Western Cape Health region of South Africa. Soc Sci Med. 1988, 7: 683-689.CrossRef
18.
Cegielski JP, Arab L, Cornoni-Huntley J: Nutritional risk factors for tuberculosis among adults in the United States, 1971–1992. Am J Epidemiol. 2012, 176 (5): 409-422. 10.1093/aje/kws007.CrossRefPubMed
19.
Edwards LB, Livesay VT, Acquaviva FA, Palmer CE: Height, weight, tuberculosis infection, and tuberculous disease. Arch Environ Health. 1971, 22: 106-112. 10.1080/00039896.1971.10665820.CrossRefPubMed
20.
Tverdal A: Body mass index and tuberculosis. Eur J Respir Dis. 1986, 69: 355-362.PubMed
21.
Zachariah R, Spielmann MP, Harries AD, Salaniponi FM: Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg. 2002, 96: 291-294. 10.1016/S0035-9203(02)90103-3.CrossRefPubMed
22.
World Health Organization: Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health. Report of the Commission on Social Determinants of Health. 2008, Geneva: World Health Organization, 27-
23.
Oxman A, Fretheim A: Can paying for results help to achieve the Millennium Development Goals? A critical review of selected evaluations of results-based financing. J Evid Based Med. 2009, 2: 184-195. 10.1111/j.1756-5391.2009.01024.x.CrossRefPubMed
24.
Lagarde M, Haines A, Palmer N: The impact of conditional cash transfers on health outcomes and use of health services in low and middle income countries. Cochrane Database Syst Rev. 2009, 4: CD008137-PubMed
25.
Lutge EE, Wiysonge CS, Knight SE, Volmink J: Material incentives and enablers in the management of tuberculosis. Cochrane Database Syst Rev. 2012, 1: CD007952-PubMed
26.
Boccia D, Hargreaves J, Lonnroth K, Jaramillo E, Weiss J, Uplekar M, Porter JDH, Evans CA: Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis. 2011, 15 (Suppl 2): 37-49.CrossRef
27.
28.
29.
Statistics South Africa: Mortality and Causes of Death in South Africa, 2009: Findings from Death Notification. 2011, Pretoria: Statistics South Africa, 81-
30.
Weijer C, Grimshaw JM, Taljaard M, Binik A, Boruch R, Brehaut JC, Donner A, Eccles MP, Gallo A, McRae AD, Saginur R, Zwarenstein M: Ethical issues posed by cluster randomized trials in health research. Trials. 2011, 12: 100-10.1186/1745-6215-12-100.CrossRefPubMedPubMedCentral
31.
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, CONSORT group; Pragmatic Trials in Healthcare (Practihc) group: Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008, 337: a2390-10.1136/bmj.a2390.CrossRefPubMedPubMedCentral
32.
Eldridge S: Pragmatic trials in primary health care: what, when and how?. Fam Pract. 2010, 27: 591-592. 10.1093/fampra/cmq099.CrossRefPubMed
33.
Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furburg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K: A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clinl Epidemiol. 2009, 62: 464-475. 10.1016/j.jclinepi.2008.12.011.CrossRef
34.
Chalkidou K, Tunis S, Whicher D, Fowler R, Zwarenstein M: The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research. Clin Trials. 2012, 9 (4): 436-446. 10.1177/1740774512450097.CrossRefPubMed
35.
36.
37.
38.
Department of Health (South Africa): Chapter 4: Diagnosis of TB. National Tuberculosis Management Guidelines. 2009, Pretoria: Department of Health (South Africa)
39.
Kipp AM, Pungrassami P, Stewart PW, Chongsuvivatwong V, Strauss RP, van Rie A: Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales. Int J Tuberc Lung Dis. 2011, 15 (11): 1540-1545. 10.5588/ijtld.10.0273.CrossRefPubMedPubMedCentral
40.
McCullagh P, Nelder JA: Generalized Linear Models. 1989, London: Chapman & Hall/CRC, 2CrossRef
41.
Martins N, Morris P, Kelly PM: Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ. 2009, 339: b4248-10.1136/bmj.b4248.CrossRefPubMedPubMedCentral
42.
Yao H, Wei X, Liu J, Zhao J, Hu D, Walley JD: Evaluating the effects of providing financial incentives to tuberculosis patients and health providers in China. Int J Tuberc Lung Dis. 2008, 12 (10): 1166-1172.PubMed
43.
Thim S, Sath S, Sina M, Penh P, Tsai E, Delagado JC, Shapiro AE: A community-based TB programme in Cambodia. JAMA. 2004, 292 (5): 566-568.CrossRefPubMed
44.
Whitworth A, Wright G, Noble M: A Review of Income Transfers to Disabled and Long Term Sick People in Seven Case Study Countries and Implications for South Africa. Working paper number 5. 2006, Oxford: University of Oxford
45.
Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F: Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011, 11: 696-10.1186/1471-2458-11-696.CrossRefPubMedPubMedCentral
46.
Brust JC, Gandhi NR, Carrara H, Osburn G, Padayatchi N: High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000–2003. Int J Tuberc Lung Dis. 2010, 14 (4): 413-419.PubMedPubMedCentral
47.
Guwatudde D, Nakakeeto M, Jones-Lopez EC, Maganda A, Chiunda A, Mugerwa RD, Ellner JJ, Bukenya G, Whalen CC: Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol. 2003, 158: 887-898. 10.1093/aje/kwg227.CrossRefPubMedPubMedCentral
48.
Alperstein G, Morgan KR, Mills K, Daniels L: Compliance with anti-tuberculosis preventive therapy among 6-year-old children. Aust N Z J Public Health. 1998, 22: 210-213. 10.1111/j.1467-842X.1998.tb01174.x.CrossRefPubMed
49.
Van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS: Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006, 10 (1): 13-18.PubMed
50.
Metadata
Title
Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial
Authors
Elizabeth Lutge
Simon Lewin
Jimmy Volmink
Irwin Friedman
Carl Lombard
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Trials / Issue 1/2013
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-14-154

Other articles of this Issue 1/2013

Trials 1/2013 Go to the issue

Study protocol

Evaluation of the acoustic coordinated reset (CR ®) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial

Study protocol

Bee venom acupuncture for the treatment of chronic low back pain: study protocol for a randomized, double-blinded, sham-controlled trial

Research

A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies

Study protocol

FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial

Study protocol

A brief intervention for weight management in primary care: study protocol for a randomized controlled trial

Study protocol

Effectiveness of off-the-shelf footwear in reducing foot pain in Australian Department of Veterans’ Affairs recipients not eligible for medical grade footwear: study protocol for a randomized controlled trial